Procyon Advisors, LLC Gilead Sciences, Inc. Transaction History

Procyon Advisors, LLC

$1.04 Billion
Q2 2025

A detailed history of Procyon Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Procyon Advisors, LLC holds 26,483 shares of GILD stock, worth $3.18 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

26,483

Previous 22,947 15.41%

Holding current value

$3.18 Million

Previous $2.57 Million 14.2%

% of portfolio

0.28%

Previous 0.16%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 09, 2025	BUY	$96.91 - $113.0 $342,673 - $399,568	3,536 Added 15.41%	26,483 $2.94 Million
Q1 2025 Apr 11, 2025	SELL	$89.14 - $117.41 $1.01 Million - $1.33 Million	-11,367 Reduced 33.13%	22,947 $2.57 Million
Q4 2024 Jan 15, 2025	SELL	$83.95 - $97.9 $162,023 - $188,947	-1,930 Reduced 5.33%	34,314 $3.17 Million
Q3 2024 Oct 11, 2024	BUY	$66.59 - $83.99 $214,020 - $269,943	3,214 Added 9.73%	36,244 $3.04 Million
Q2 2024 Aug 02, 2024	SELL	$63.15 - $72.88 $75,906 - $87,601	-1,202 Reduced 3.51%	33,030 $2.27 Million
Q1 2024 Apr 15, 2024	BUY	$71.58 - $87.29 $283,098 - $345,231	3,955 Added 13.06%	34,232 $2.51 Million
Q4 2023 Jan 18, 2024	BUY	$73.27 - $83.09 $92,540 - $104,942	1,263 Added 4.35%	30,277 $2.45 Million
Q3 2023 Oct 10, 2023	BUY	$73.94 - $80.67 $864,210 - $942,870	11,688 Added 67.46%	29,014 $2.17 Million
Q2 2023 Jul 17, 2023	BUY	$76.01 - $86.7 $550,768 - $628,228	7,246 Added 71.88%	17,326 $1.34 Million
Q1 2023 Apr 10, 2023	SELL	$77.31 - $88.08 $462,236 - $526,630	-5,979 Reduced 37.23%	10,080 $836,000
Q4 2022 Jan 19, 2023	SELL	$62.32 - $89.47 $123,580 - $177,419	-1,983 Reduced 10.99%	16,059 $0
Q3 2022 Oct 17, 2022	BUY	$59.54 - $68.01 $64,719 - $73,926	1,087 Added 6.41%	18,042 $1.11 Million
Q2 2022 Jul 11, 2022	SELL	$57.72 - $65.01 $57,720 - $65,010	-1,000 Reduced 5.57%	16,955 $1.05 Million
Q1 2022 Apr 18, 2022	SELL	$57.92 - $72.58 $288,441 - $361,448	-4,980 Reduced 21.71%	17,955 $1.07 Million
Q4 2021 Jan 18, 2022	BUY	$64.88 - $73.64 $78,439 - $89,030	1,209 Added 5.56%	22,935 $1.67 Million
Q3 2021 Oct 14, 2021	BUY	$67.69 - $73.03 $550,319 - $593,733	8,130 Added 59.8%	21,726 $1.52 Million
Q2 2021 Jul 22, 2021	BUY	$63.47 - $69.35 $862,938 - $942,882	13,596 New	13,596 $936,000
Q4 2020 Jan 19, 2021	SELL	$56.65 - $64.55 $188,304 - $214,564	-3,324 Closed	0 $0
Q3 2020 Oct 22, 2020	SELL	$62.1 - $78.08 $9,998 - $12,570	-161 Reduced 4.62%	3,324 $210,000
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $81,888 - $95,088	1,132 Added 48.11%	3,485 $268,000
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $11,398 - $14,600	182 Added 8.38%	2,353 $176,000
Q4 2019 Feb 21, 2020	BUY	$61.62 - $67.78 $133,777 - $147,150	2,171 New	2,171 $141,000

Others Institutions Holding GILD

# of Institutions

2,298

Shares Held

Call Options Held

9.42M

Put Options Held

9.72M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $150B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Procyon Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Procyon Advisors, LLC with notifications on news.

Account

Procyon Advisors, LLC Gilead Sciences, Inc. Transaction History